Increased collagen, per se, may not affect left ventricular function in spontaneously hypertensive rats

Area of Science:

• Cardiovascular Research
• Cardiac Fibrosis
• Matrix Metalloproteinase Inhibition

Background:

• Left ventricular fibrosis is a key factor in cardiac dysfunction.
• Quantifying fibrosis's role is challenging due to concurrent myocyte and vascular changes.
• Matrix metalloproteinase (MMP) inhibitors can induce collagen accumulation.

Purpose of the Study:

• To investigate the specific role of myocardial fibrosis in cardiac dysfunction.
• To determine if doxycycline-induced collagen accumulation affects cardiac function.
• To isolate the impact of fibrosis from other pathological changes.

Main Methods:

• Adult male spontaneously hypertensive rats were used.
• One group received doxycycline (MMP inhibitor) for 6 months; a control group received no treatment.
• Cardiac function, arterial pressure, aortic stiffness, and myocardial collagen were assessed.

Main Results:

• Doxycycline treatment significantly increased ventricular collagen concentration.
• Arterial pressure and aortic stiffness remained unchanged.
• Left ventricular function, including dP/dt and diastolic time constant, was unaffected.

Conclusions:

• Moderate collagen accumulation alone does not adversely affect cardiovascular function.
• Other collagen modifications, such as advanced glycation end-products, may drive fibrosis-related dysfunction.
• This study helps differentiate the direct impact of fibrosis on cardiac health.